Login / Signup
Both serum and tissue Galectin-1 levels are associated with adverse clinical features in neuroblastoma.
Yeming Wu
Yuanxia Cai
Min Zhang
Zhixiang Wu
Yeming Wu
Published in:
Pediatric blood & cancer (2018)
Tissue and serum Galectin-1 levels were associated with adverse clinical features in patients with neuroblastoma, and sGalectin-1 could be a potential biomarker for monitoring therapy.
Keyphrases
</>
stem cells
adverse drug
emergency department
mesenchymal stem cells
electronic health record